Dmitry I Gabrilovich

28PUBLICATIONS
214CO-AUTHORS
Receptors and membrane biologyHaematological tumoursImmunogenetics (incl. genetic immunology)Plant and fungus systematics and taxonomyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jun 17, 2026
15-LOX-catalytic bias towards ether-(alkenyl)-ETE-PEs oxidation bestows selectivity of PRO-ferroptotic cell death signaling.

|May 12, 2026
Harnessing myeloid cell plasticity for cancer therapy.

|Jan 02, 2025
The heterogeneity of neutrophils in cancer and its implication for therapeutic targeting.

Evgeniy Eruslanov, Yulia Nefedova, Dmitry I Gabrilovich

|Jul 05, 2024
Defining myeloid-derived suppressor cells.

Leila Akkari, Ido Amit, Vincenzo Bronte

|Feb 29, 2024
A guideline on the molecular ecosystem regulating ferroptosis.

Enyong Dai, Xin Chen, Andreas Linkermann

|Feb 24, 2024
The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment.

Elizabeth L Hardaker, Emilio Sanseviero, Ankur Karmokar

Pageof 5

Frequent Collaborators

5 joint publications

Yulia Nefedova

5 joint publications

Cindy Lin

4 joint publications

Valerian E Kagan

4 joint publications

Serge Y Fuchs